The Oberschleißheim, Germany-based Institute of Biological and Medical Imaging developed a novel hybrid endoscopic instrument for esophageal cancer diagnosis and staging, News Medical Life Sciences reports.
Here's what you should know.
1. Vasilis Ntziachristos, PhD, and researchers said the device may reduce unnecessary biopsies and facilitate early-disease detection allowing therapy to start sooner.
2. Horizon 2020, a European Union research program, awarded $1,059,705 to the researchers.
3. Researchers believe the device can have other gastroenterological endoscopy impacts. It allows for three-dimensional esophageal wall imaging and disease biomarkers quantitation.
4. The device may drastically improve care quality in rural and urban settings, researchers believe.